Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:2-Octenoic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004194 AN006967 PfK13-associated artemisinin resistance slows drug activation and enhances antioxidant defence, which can be overcome with sulforaphane Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003880 AN006373 Untargeted metabolome analysis of control and disease intervertebral disc tissue Tissue Human Bone disease Ganga Orthopaedic Research and Education Foundation LC-MS
ST003482 AN005718 Tissue niche influences immune and metabolic profiles to Staphylococcus aureus biofilm infection (Intracellular data) Intracellular Granulocyte Mouse Bacterial infection University of Nebraska Medical Center LC-MS
ST002866 AN004699 The role of PFAS exposures in nonalcoholic fatty liver disease and hepatocellular carcinoma in the Multiethnic Cohort Blood Human Cancer University of Southern California LC-MS
ST002866 AN004699 The role of PFAS exposures in nonalcoholic fatty liver disease and hepatocellular carcinoma in the Multiethnic Cohort Blood Human NASH University of Southern California LC-MS
ST002447 AN003988 Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals Bacterial cells Pseudomonas aeruginosa Bacterial infection Sharjah Institute for Medical Research LC-MS
ST002108 AN003449 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000150 AN000237 Association of Metabolic Profile and Microbiome in Chronic Pressure Ulcer Wounds Ulcer biopsies Human Enterocolitis Montana State University NMR
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo